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Summary 
Long-term bone marrow cultures have been useful in determining gene expression patterns in 
pre-B cells and in the identification of cytokines uch as interleukin 7 (IL-7). We have developed 
a culture system to selectively grow populations of B lineage restricted progenitors (pro-B cells) 
from murine bone marrow. Pro-B cells do not grow in response to IL-7, Steel locus factor (SLF), 
or a combination of the two. c-kit, the SLF receptor, and the IL-7 receptor are both expressed 
by pro-B cells, indicating that the lack of response is not simply due to the absence of receptors. 
Furthermore, SLF is not necessary for the growth of pro-B cells since they could be expanded 
on a stromal ine derived from Steel mice that produces no SLF. ILo7 responsiveness in pre-B 
cells is associated with an increase in n-myc expression and is correlated with immunoglobulin 
(Ig) gene rearrangements. Although members of the ets family of transcription factors and the 
Pim-1 kinase are expressed by pro-B cells, n-myc is not expressed. Pro-B cells maintain Ig genes 
in the germline configuration, which is correlated with a low level of recombination activating 
genes 1 and 2 (Rag-1 and 2) mRNA expression, but high expression of sterile/z and terminal 
deoxynucleotidyl transferase. Pro-B cells are unable to grow separated from the stromal ayer 
by a porous membrane, indicating that stromal contact is required for growth. These results 
suggest that pro-B cells are dependent on alternative growth signals derived from bone marrow 
stroma and can be distinguished from pre-B cells by specific patterns of gene expression. 
O ur goal has been to develop an in vitro system to selec- tively grow large numbers of primitive B cells in order 
to identify genes and growth factors that regulate arly B 
cell development. The use of long-term bone marrow cul- 
ture systems (1) and transformation fpre-B cells by A-MuLV 
has permitted detailed analysis of pre-B and more mature cells 
of the B lineage (2-5). In contrast, little is known about he 
earliest phases of B cell development because of problems in 
obtaining stable populations of progenitor cells. Stages in the 
development of B cells within the bone marrow can be defined 
by Ig gene rearrangements, growth requirements, and the 
expression of specific genes and surface markers (for a review 
see reference 2). The progenitor B (pro-B): cell is the most 
primitive cell of the B lineage. We define it as a B lineage 
I Abbreviations u ed in this paper: CM, conditioned medium; IGF, insulin- 
like growth factor; pro, progenitor; SLF, Steel locus factor; TdT, terminal 
deoxynucleotidyl transferase. 
restricted cell that retains Ig genes in the germline configura- 
tion and has the capacity to differentiate into mature B cells 
expressing diverse antigen receptors. Bone marrow sorted on 
the basis of antigen expression has revealed that pro-B cells 
express the pan-B cell antigen, B220, and low levels of Thy-1 
(6-8). 
The earliest stage of B lymphopoiesis that has been exten- 
sively characterized is the immature pre-B cell. These cells 
have rearranged D and J region segments on at least one al- 
lele of the Ig H chain locus and express B220. The surrogate 
L chains X5 and Vpre-B and the mtvl/B29 genes, whose prod- 
ucts are essential for the export of IgM to the surface of B 
cells (9-11), are expressed atthis stage. Immature pre-B cells 
require signals derived from stroma in addition to ILo7 for 
growth (8, 12). 
Immature pre-B cells differentiate into pre-B cells upon 
productive V-DJ region joining and expression of/Z protein 
in the cytoplasm (C/z). IL-7 stimulates pre-B cells to divide 
in the absence of stroma (13-15), and IL-7 can synergize with 
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Steel ocus factor (SLF) to provide a potent growth stimulus 
for these ceils (16, 17). Production of functional Ig L chain 
and surface xpression of IgM, IgD, and Ia molecules corre- 
lates with the accumulation ofB ceils in the periphery, and 
a loss of responsiveness to Ib7 (8). 
Several techniques that employ the use of stromal cell lines 
and exogenous growth factors have been used to grow clonal 
lines that exhibit characteristics ofprimitive B ceils (16, 18, 
19). The phenotypes ofthese immature B cell dories are quite 
variable with respect o the expression of the B220, Ly-1, 
and Mac-1 antigens. This disparity may reflect he outgrowth 
of unusual cell phenotypes due to the extreme sdection of 
cloning procedures. 
In vitro culture systems to grow populations of B lineage 
calls can be used to avoid clonal variation. Two modifications 
of long-term bone marrow cultures (1) were made to isolate 
populations ofpro-B cells (20). First, bone marrow calls were 
infected with a retroviral construct containing the P210 
BCR/ABL gene, and second, the ceils were plated onto a 
stromal cell line, called $17. $17 supports the growth of B 
lineage calls (21) and does not produce detectable vels of 
Ib7 or its mRNA as assessed by bioassays and the PCR (20, 
22). In the absence of IL-7, pre-B calls do not dominate the 
cultures and clonal populations of pro-B cells with germline 
Ig genes were expanded (20). One drawback to this system 
was the expression of the oncogene which could obscure 
growth factor requirements. 
Recently, we described a culture system (23) to grow popu- 
lations of pro-B cells from murine bone marrow on $17 in 
the absence of the BCR/ABL oncogene. These cultures offer 
a reproducible t chnique for growing highly enriched popu- 
lations of pro-B ceils in a short period of time. In this report, 
we have used these cells to investigate gene expression and 
growth factor equirements ofpro-B cells. The results of these 
experiments indicate that pro-B cells can be clearly separated 
from the pre-B cells stage of lymphopoiesis by their pattern 
of gene expression and response to specific ytokines. We show 
that pro-B ceils are dependent on stromal-derived signals dis- 
tinct from ID7 and SLF. The system utilized here should be 
useful in identifying signals that are critical for pro-B cell 
growth. 
Materials and Methods 
Mice. BALB/cAN mice were bred and maintained in our colony 
at the University of California, Los Angdes. 
Culture Conditions for Pro-B Cells. Initiation of pro-B cell cul- 
tures requires two steps: the establishment of semiconfluent $17 
monolayers and the plating of BALB/c bone marrow onto the $17. 
All cells were grown in RPMI 1640 (Gibco BILL, Gaithersburg, 
MD) medium supplemented with 5% FCS and 50/~M 2-ME. Ap- 
proximately 5 x 104 $17 cells were plated on 6 cm 2 petri dishes 
(Coming Inc., Corning, NY) in 5 ml medium and allowed to ex- 
pand until *80% confluent (2-3 d). Single cell suspensions of bone 
marrow isolated from the femurs and tibias of 3-4-wk-old BALB/c 
mice (24) were washed and plated at 104 cells/ml onto the S17 
coated ishes (5 ml per dish). Cultures were fed biweekly as de- 
scribed by Whitlock et al. (24). On days 3-4 of each week, 2 ml 
fresh medium was added per dish, and on day 4 of each week, 75% 
of the medium from each dish was replaced. After 3-4 wk, pro-B 
cells were harvested by collecting all medium and then gently 
washing the $17 layer with cold PBS. Approximately 2-4 x 106 
pro-B cells are recovered per 6 cm 2 dish. 
Cultures w~re also performed by inserting diffusion chambers 
(Transwells| Costar Corp., [Cambridge, MA], 0.4-/~m pore size; 
or cell culture inserts Cyclospore; Falcon Labware [Oxnard, CA], 
0.45-~m pore size) into the wells of a 24-well dish containing 
preestablished $17 layers. 10 s pro-B cells were plated per well. 
Cytokines. Recombinant rat-SLF was kindly provided by K. 
Zsebo and I. McNiece (Amgen Biologicals, Thousand Oaks, CA). 
Recombinant human-M-CSF was provided by G. Baldwin (Depart- 
ment of Hematology and Oncology, University of California, Los 
Angeles, CA). The source of IL-7 was an IL-7 containing COS su- 
pernatant produced as described (25). Briefly, subconfluent mono- 
layers of COS ceils were transfected by a DEAE-dextran-chloroquine 
method using 15 g of pcDL-SR (Ib7) plasmid. IL-7 containing su- 
pernatants were collected 3 d after transfection a d titrated on an 
IL-7-dependent pre-B cell line, clone H (25). 
Flow Cytometry. Cells were stained with a variety of murine- 
specific mAbs. CD45R (anti-B220 mAb; Pharmingen, San Diego, 
CA) was conjugated toPE. Goat anti-mouse/~ mAb conjugated 
to FITC was used to detect both surface and cytoplasmic expres- 
sion of Ig/~ protein. The anti-c-k/t biotin-conjugated antibody (2]38) 
was a gift from K. Ikuta and I. Weissman (Stanford University, 
Stanford, CA) (26, 27). 
To detect surface xpression fB220, cells were incubated with 
the appropriate mAb for 30 min on ice, washed twice with PBS, 
2% FCS and 0.2% sodium azide, and fixed in 1% paraformalde- 
hyde. To detect c-hit expression, the cells were first incubated with 
2B8, and then incubated an additional 30 rain on ice with PE-strep- 
tavidin before fixation. To detect cytoplasmic # expression, cells 
were fixed in 1% paraformaldehyde overnight, incubated with anti-# 
mAb for 15 min in PBS, 0.05% Triton X-100, then incubated an 
additional 15 rain in PBS, 0.1% Triton X-100. 
All samples were simultaneously analyzed using isotype con- 
trois. Antigen expression was measured using a FACScan | flow 
cytometer and Lysis II software (Becton Dickinson & Co., San 
Jose, CA). 
The fluorokine routine II.,7 biotin kit (R & D Systems, Inc., 
Minneapolis, MN) was used to detect IL-7 receptors. The protocol 
provided by the manufacturer was followed. Cells were incubated 
first with biotin-conjugated recombinant IL-7 and then with 
PE-streptavidin, and then washed and run on the FACScan | flow 
cytometer. 
Nucleic Acid Analysis. High molecular weight DNA was pre- 
pared and analyzed as described (28). Total RNA was prepared by 
lysing cells in 4 M guanidinium isothiocyanate nd spinning the 
extract through aCsC1 cushion (29). All probes were labeled with 
ot-[3zp]ATP by random-primed DNA labeling (Boehringer Mann- 
heim Corp., Indianapolis, IN) and had specific activities of "~109 
cpm//~g of DNA. Descriptions ofspecific probes and restriction 
enzyme digests are given in the figure legends. 
PCR Analysis. RNA was prepared asabove. The PCR strategy 
used by Pleiman et al. (30) was followed to detect Ib7K mKNA. 
Sequences ofthe oligonucleotide primers were as follows: primer 
1, 5' TTACTTCAAAGGCTTCTGGAGC primer 2, 5' CTGGCT- 
TCAACGCCTTTCACCTCA. The protocols used by Young et 
al. (25) for generation fcDNA and PCR were followed with the 
following modification. Primer I was used to generate cDNA, the 
annealing temperature used in the PCR reaction was 60~ and 
30 cycles of PCK were performed. 10% of the reaction product 
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was separated on a 2% agarose gel and visualized by thidium bro- 
mide staining. 
Resu l ts  
Cells Cultured on S17 Stroma Retain Ig Genes in the Germline 
Configuration. Large numbers ofpro-B cells were produced 
for phenotypic analysis using the pro-B cell culture system 
that has been previously described (23). Pro-B cell cultures 
were initiated by plating murine bone marrow on $17 stromal 
layers. Cells harvested after 3-4 wk in culture exhibited a 
monomorphic ellular morphology characteristic of small- 
and medium-sized lymphocytes. Greater than 70% of the 
pro-B cells in the population expressed the B220 antigen. 
The cells were negative for the myeloid surface antigen Mac-1 
and for mature T cell antigens (CD3, CD4, and CD8), but 
expressed low levels of Thy-1. Less than 2% of the cells ex- 
pressed C/z, and slgM was not detected on any cells within 
the pro-B cell population. These cells could differentiate into 
mature Ig-secreting B cells in the SCID mouse (23). 
To determine the g ne rearrangement status of the cells 
growing on $17, DNAs collected from cells growing in seven 
individual cultures were subjected to Southern (DNA) blot 
analysis. The results in Fig. 1 reveal that most of the cells 
retained IgH genes in the germline configuration. The ap- 
parent discrepancy in the migration of the 6.2-kb germline 
fragment between the pro-B cells and liver (Fig. 1) can be 
ascribed to a gel artifact. The germline DNA fragment of 
liver comigrates with that of the pro-B cells on numerous 
other autoradiograms. We have chosen to present the autora- 
diogram in Fig. 1 because it contains DNA from seven in- 
dividual pro-B cells cultures. TCR 3' chain genes are also in 
the germline configuration (data not shown). A subset of 
the cultured cells (estimated visually at <10%) has begun 
H chain gene rearrangements (Fig. 1). These rearrangements 
probably represent D-J joining since the sizes of the DNA 
fragments correspond to those previously shown to be DJ 
rearrangements (31-33). 
Expression of Genes Associated with the Recombination Ma- 
chinery. The paucity of rearrangement at he IgH locus raised 
the possibility that essential components of the recombina- 
tion machinery were not expressed in pro-B cells. Transcrip- 
tion of the/x locus correlates with accessibility of this locus 
for recombination (3). After # transcription, endonucleolytic 
Figure 1. Pro-B cells retain Ig H chain genes in germline configura- 
tion. High molecular weight DNA was isolated from seven individual 
6-cm2 dishes of pro-B cells (lanes I-7) 3 wk after establishment of he 
culture. 10/~g of DNA was digested with EcoRI, electrophoresed through 
0.8% agarose gel, transferred to nitrocellulose, and probed with the 1.8-kb 
H chain J fragment (56). The blot was exposed to film at -70~ for 
16 h. BALB/cAN liver DNA (L) was used as a germline (GL) control. 
cleavages are made between coding and recombination signal 
sequences, followed by exonucleolytic degradation at the 
coding sequences. The end can then be resynthesized by a 
template-independent ac ivity, terminal deoxynucleotidyl 
transferase (TdT), which creates N region sequences at the 
joints between D. and J. or V. and DJ. Finally, the two 
coding strands are ligated. The Rag-1 and Rag-2 genes are 
active in this recombination process (34, 35), however, their 
precise role is unclear (for a review of V(D)J recombination 
see reference 36). 
Sterile transcripts of the/z locus were present at high levels 
in the pro-B cells (Fig. 2). This indicated that the lack of 
recombination i the pro-B cells was not due to inaccessi- 
bility of the locus. TdT was also highly expressed in the pro-B 
cells (Fig. 2). Thus, an absence of TdT could not explain the 
germline status of the Ig genes in the pro-B cells. However, 
Rag-1 and Rag-2 mRNA transcripts were detected at very 
low levels (Fig. 2). Rag expression was detected in the thymus 
after an 8-h exposure. However, to detect he Rag genes in 
pro-B cells and bone marrow, a 4-d exposure of the blot was 
necessary. The level of Rag message in the pro-B cells is com- 
parable with that in bone marrow hich consists of >80% 
myeloid cells that do not express the Rag genes. The germ- 
line status of the majority of the IgH genes in the pro-B cells 
within the population correlates with, and may be a direct 
reflection of, the low levels of Rag gene expression. 
Despite the low frequency of rearrangements, the B29 gene 
was highly expressed in the pro-B cells (Fig. 2). The ]is gene 
is also expressed (data not shown). The B29 gene product 
is essential for the export of IgM to the surface of B cells 
and the 2is gene encodes a surrogate L chain (10). The data 
presented here indicate that these genes are expressed before 
Ig gene rearrangements. 
Fig. 2 indicates that the level of actin expression is lower 
in the pro-B cells than in the tissue samples. This may be 
a result of less pro-B cell RNA on the gel. However, the 
difference in actin expression may reflect the fact that the 
Figure 2. Northern blot anal- 
)'sis of genes associated with re- 
combination. Total cytoplasmic 
RNA (20/~g) was denatured, frac- 
tionated on a formaldehyde-l% 
agarose gel, transferred to nylon- 
backed nitrocellulose, blotted with 
the indicated probes, and exposed 
to film for the amount of time in- 
dicated in parentheses. Probes: 
400-bp fragment from the Ig 
# C region (I h) (34); full-length 
TdT fragment (2 h) (57); 1.3-kb 
Rag-1 fragment (4 d) (35); full- 
length Rag-2 fragment (4d) (35); 
1-kb B29 fragment (3 h) (58); and 
a Puc19 plasmid containing a full- 
length actin cDNA (16 h). Sizes 
of transcripts are indicated. 
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spleen, bone marrow, and thymus samples include connec- 
tive tissue that is rich in actin, and the pro-B cells are an 
enriched population of hematopoietic cells with no connec- 
tive tissue. 
Pro-B Cells Express Ets Family Proteins, but Not n-mya Pro-B 
cells were analyzed further by Northern blot analysis to mon- 
itor genes that regulate arly B cell development. The Ets 
family of putative transcription factors, which includes Ets-1, 
Pu.1, and Fli-1, has been shown to be expressed in lymphoid 
tissues and cell lines of mature B lineage cells (37-39). Fig. 
3 A demonstrates that Ets-1, Pu.1, and Fli-1 are all expressed 
in pro-B cells, indicating that they may be involved in the 
transcription of genes expressed at the earliest stages of B 
cell development. 
n-myc and c-myc belong to a family of cellular proto- 
oncogenes that are involved in the regulation of transcrip- 
tion (40). c-myc is expressed in pre-B cell lines 38B9 and C1 
18.81, as well as in the immature pre-B cell line HAFTL-1 
and the pro-B cells (Fig. 3). In contrast, n-myc is expressed 
in the pre-B cells lines, but not in HAFTb l  or the pro-B 
cells. This implies that n-myc is not essential for the growth 
of pro-B cells, and its expression may mark the pro/pre-B 
cell junction (41). 
The Pim-1 proto-oncogene encodes aprotein-serine/threo- 
nine kinase (42) that is expressed at high levels in the lym- 
phoid tissues and cell lines of both myeloid and lymphoid 
origin (43). Pim-1 is expressed in the two pre-B cell lines 
tested, the HAFTL-1 cell line, and the pro-B cells (Fig. 3 b). 
The results presented thus far indicate that pro-B cells can 
be distinguished from pre-B cells by their germline Ig H chain 
genes, absence of n-myc transcripts, and paucity of Rag-1 and 
Rag-2 mRNAs. 
Neither IL7 Nor SLF Is Su.~cient to Maintain the Growth 
of Pro-B Cells. Three components have been identified as 
playing a role in the growth of early B lineage cells: stroma, 
IL-7, and SLF. The role of soluble Ib7 and SLF in the growth 
of pro-B cells was assessed by removing them from the stromal 
layer and replating them at a concentration of 105 cells/ml 
in either medium alone or medium supplemented with growth 
factors. After 3 d under these conditions, net growth was 
determined by viable cell counts. The initial seeding concen- 
tration was chosen to minimize crossfeeding and to ensure 
a detectable change in cell number over the assay period. 
In each experiment, an IL-7-responsive, pre-B cell line (done 
H; 25) and an SLF-responsive line (NSF/60; 44) were included 
as controls. Clone H increased an average of eightfold (range, 
6.1-10.4) when grown under conditions in which 0.2% of 
Figure 3. Pro-B cells express the Ets family of transcription factors, 
Pim-1, and c-myc, but not n-my. Blots were prepared as described in Fig 
2. (A) Probes: full-length cDNA of Ets-1 (8 h) (37); PU.1 ( 6 h) (38); 
and Fli-1 (14 h) (59). For a measure of the amount ofRNA loaded, an 
actin probe was used (see Fig. 2). (B) Probes: exon 3 of murine n-rayc 
which crosshybridizes with c-rayc (72 h); 1-kb Pim-1 fragment (16 h); and 
a Puc19 plasmid containing a full-length cDNA of actin(6 h). 
Figure 4. IL-7 and SLF fail to support the growth of pro-B cells. Pro-B 
cells were harvested after 3 wk in culture, washed, and plated at 10 s 
cells/ml in 1 ml on 24-well cluster dishes under the conditions ndicated. 
After 3 d, all cells were harvested and viable cells were enumerated on 
the basis of trypan blue exclusion. The results of three separate experi- 
ments are depicted. Experiment 3 has been ormalized to an input cell 
number of 10 s from 3 x 105. rSLF (Amgen Biologicals) was used at a 
concentration f 250 ng/ml. The source of 1I.-7 was an Ib7-containing 
COS supernatant (25), which was used at 0.2% ofthe culture volume. 
S17CM was collected from a confluent 817 stromal hyer 24 h after changing 
the medium. The results represent the mean and SE (bars) of triplicate 
samples from each experiment. 
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the culture volume was Ib7 containing COS supematant (25). 
NSF/60 increased an average of 13-fold (range, 9.8-15.0) in 
medium supplemented with 250 ng/ml SLF (data not shown). 
Pro-B cell numbers increased to an average of three times 
(range, 2.6-3.8) their initial number when grown on the S17 
stromal layer. Cells cultured in either 250 ng SLF, 0.2% IL-7, 
or a combination ofthe two did not increase in number (Fig. 
4). In fact, the number of viable cells recovered after 3 d under 
these conditions was less than the number initially plated, 
suggesting that cells had died. Similar results were obtained 
using various concentrations of SLF (5-500 ng/ml) and IL-7 
(0.1-10% IL-7-containing COS supernatant) in seven sepa- 
rate experiments (data not shown). 
Pro-B cells were also incubated in medium that had been 
conditioned by $17 for 24 h ($17 conditioned medium [CM]) 
to determine if a soluble factor produced by $17 could sup- 
port growth. Pro-B cells did not usually replicate under these 
conditions (Fig. 4). However, this result is variable since in 
two out of seven experiments cells replicated to an average 
of 1.5 times their original number in S17CM (data not shown). 
To determine if either 11.-7 or SLF could cooperate with 
factors ecreted by $17 to support he growth of pro-B cells, 
cells were incubated in S17CM plus either factor. The com- 
bination of either IL-7 or SLF with S17CM did not support 
growth (Fig. 4). These experiments imply that, unlike pre-B 
cells, the growth of pro-B cells cannot be sustained in II.-7 
and SLF. 
Pro-B Cells Express c-kit and the IL 7 Receptor. The lack 
of growth in response to II.-7 and SLF may be due to the 
absence of the receptors for these factors on the pro-B cells. 
To determine if c-kit (the SLF receptor) was expressed on pro-B 
cells, cells were incubated with an anti-c-kit mAb (2B8; 26) 
and subjected to flow cytometry. The 2B8 antibody recog- 
nizes c-kit on Ib3-dependent mast cells derived from +/+ 
and W/+ mice, but not on mast cells derived from W/W 
mice (26). Because the W allele has a deletion of the trans- 
membrane domain of c-kit, W/W mast cells cannot express 
c-kit on their surface (27). Staining of three populations of 
pro-B cells revealed that an average of 85% (range, 76-90) 
of them expressed the SLF receptor (Fig. 5 A). 
Since no antibodies to the IL-7 receptor (IL-7P-,) were avail- 
able, two independent assays were used to demonstrate that 
the Ib7P, is expressed by pro-B cells. First, to detect IL-7R. 
mRNA, PCR. was used toamplify a specific fragment after 
reverse transcription of pro-B cell P..NA. As seen in Fig. 5 
B, IL-7R message was present in pro-B cells and the pre-B 
cell lines (70Z/3, done H). Ib7P, mR.NA was not detected 
in the myeloid line 32D or the mature B cell line WEHI- 
231, which served as negative controls. Second, to determine 
if the cells could specifically bind ILo7, they were incubated 
with fluorescently abeled IL-7 and then analyzed by flow 
cytometry. An average of 75% (range, 67-92) of the cells 
in the pro-B cell population bound IL-7 specifically. This was 
comparable to the 70Z/3 pre-B cell ine in which 90% (range, 
87-95) of the cells bound the factor. Taken together, the data 
in Fig. 5 indicate that pro-B cells do express receptors for
both SLF and IL-7. Thus, the lack of response to these factors 
cannot be simply explained by the absence of receptors. 
Stromal Lines that Genetically L ck the SLF Gene Support 
the Growth of Pro-B Cells. The experiments presented above 
indicated that neither soluble SLF nor IL-7 provided sufficient 
signals to support he growth of pro-B cells, but did not es- 
tablish whether or not these cytokines were necessary for 
growth. It is unlikely that Ib7 is required for growth since 
$17 does not produce IL-7 as assessed bybioassays or PCP, 
(20, 22). $17 does produce SLF (22), and thus this factor may 
be required for the growth of pro-B cells. 
To determine if SLF is essential for the growth of pro-B 
cells, we have utilized a stromal cell line $1/$1 which was 
derived from long-term arrow cultures of homozygous $1/$1 
Figure 5. Pro-B cells express the c-kit and 1I.-7 
receptors. (A) c-kit expression the pro-B cells. Pro-B 
cells were harvested from $17 and incubated first with 
biotin-2B8 (anti-kit; 44) and then with PE-streptavidin. 
Background staining was determined by staining cells 
in only PE-streptavidin. (B) ID7R message d tection 
by PCR. Primers were prepared todetect nucleotide 
sequences 676-990 of murine IL-7R cDNA (60). 
mRNA was extracted from the myeloid line 32D, the 
B cell ine WEHI-123, two pre-B cell ines (clone H, 
70Z/3), and the pro-B cells, cDNA was made using 
the downstream primer and reverse transcriptase, and 
then PCR was performed. Molecular weight markers 
(MW) (123-kb ladder; Gibco BILL). (C) Detection of
IF7 R. by binding labeled Ib7. Pro-B calls and the 
cell lines indicated were washed, incubated with an 
rlb7-biotin conjugate, and then incubated with strep- 
tavidin-PE. Background staining was determined by 
incubating cells in only PE-streptavidin. 
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Figure 6. Pro-B cells grow on stroma derived from Steel mice. Pro-B 
cells were harvested from $17 3-4 wk after establishment of he culture. 
Cells were washed and 9 x 10 s (3 x 105 cells/ml) were plated in 3 ml 
of medium on the indicated stroma in 6-well cluster dishes.After 4 d, 
all cells were harvested and the total number of viable cells were counted 
on the basis of trypan blue exclusion. 300 ng rSLF was added at the initia- 
tion of the experiment as indicated. The results represent the mean and 
SE (bars) of triplicate samples from three different experiments. Experiment 
3 has been normalized to an input number of9 x 10 s cells from 106. 
Figure 7. Pro-B cells are dependent on stromal contact for growth. 
Pro-B cells were harvested from $17 3-4 wk after establishment, washed, 
and replated at10 s cells/ml in 24-well plates in which a subset of the wells 
had been coated with $17. As indicated, a portion of the wells contained 
a diffusion chamber (hart/or) that inhibited pro-B cells from contacting 
the $17 stromal layer. 6 d after plating, viable cells were counted based 
upon trypan blue exclusion. The results represent the mean and SE (bars) 
of triplicate samples from three separate experiments. 
null mutant embryos in which the Steel gene was deleted 
(45, 46). These mice have impaired development of neural 
crest-derived melanocytes, germ cells, and hematopoietic cells, 
and do not produce any SLF. 
Pro-B cells were carefully removed from the S17 stromal 
layer by gentle pipetting so that very few S17 cells were re- 
moved. They were then washed and replated on either the 
S1/S1 or $17 stromal ine or into tissue culture dishes that 
contained no stroma. 4 d after transfer, all ceils were har- 
vested and counted. No growth was observed in the absence 
of stroma, indicating that a significant number of S17 ceils 
were not ransferred. After incubation on the S1/S1 stroma, 
the number of cells recovered was an average of sevenfold 
higher (range, 3.3-11.6) than the initial number of cells (Fig. 
6). Pro-B cells grown on S17 increased an average of eight- 
fold (range, 5.5-10.3). Addition of SLF to pro-B cells ex- 
planted onto S17 or S1/S1 stroma did not change the growth 
rate compared with cultures with no exogenous growth factors 
(Fig. 6). The results of these experiments support the con- 
clusion that SLF is not essential for the growth of pro-B cells. 
The Majority of the Pro-B Cells Are Dependent on Stromal 
Cell Contact.for Survival. Pro-B cells appear to be dependent 
on signals derived from the stromal ayer for growth. How- 
ever, they did not grow well in S17CM (Fig. 4), indicating 
that they may be dependent on stromal contact, amembrane- 
bound growth factor, or a labile growth factor produced by 
the stroma. Previous work with stromal cell cultures has led 
to the suggestion that the earliest B lineage progenitors are 
absolutely dependent on signals mediated by direct contact 
with the layer, whereas latter stages are relatively contact in- 
dependent (8, 47, 48). 
To assess the importance of intercellular contact between 
pro-B cells and stromal cells, pro-B cells were separated from 
the stromal ayer by a porous membrane. The surface of a 
24-well tissue culture plate was coated with $17 stromal cells. 
Once the stromal layer was confluent, the medium was 
changed and 24 h later, 10 s pro-B cells were added either 
directly on the stroma or into diffusion chambers uspended 
over the stroma. This protocol allowed the medium in which 
the cells were plated to be preconditioned by the $17 stroma. 
Pro-B cells were also plated either directly on wells that con- 
tained no stroma, or suspended over plastic in diffusion 
chambers. All cells were harvested and counted 6 d after 
transfer. On average, a sixfold increase in cell number was 
observed (range, 3.5-10.0) in cultures grown in contact with 
$17 (Fig. 7). When contact with $17 was prohibited by the 
diffusion chamber, the net increase in cell number was 1.5 
(range, -0.4-4.0; Fig. 7). Daily observation of these cul- 
tures revealed that after 3 d, >80% of the cells had died. The 
cells that survived this 3-d period grew rapidly to form small 
loci. These results indicate that the majority of the cells within 
the pro-B cell population are dependent on stromal contact 
for growth, but a subpopulation can respond to a factor 
secreted by the stromal layer. 
Discussion 
We have developed a system to reproducibly grow large 
populations (106 cells per 6 cm 2 dish) of pro-B cells that have 
the capacity to differentiate into mature Ig-secreting B cells 
in SCID mice (23). These cells were grown in medium sup- 
plemented with 5% FCS, but no additional growth factors. 
Thus, this system provides an opportunity to determine the 
factors that are important in early B cell growth and differen- 
tiation. Using this system, we found that transcription of 
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sterile # and TdT precede IgH gene rearrangements and syn- 
thesis of mRNA for Rag-1 and Rag-2 during B cell devel- 
opment. 
The pro-B cells that populate the cultures described here 
fall within a fraction of normal bone marrow isolated by Hardy 
et al. (8) that expressed B220, retained Ig H chain genes in 
the germline configuration, and was dependent on stromal 
contact for growth. Two different groups have reported the 
isolation of B lineage clones that retain Ig genes in the germ- 
line configuration (16, 18, 19). The phenotype of these clones 
did not resemble any of the bone marrow fractions described 
by Hardy et al. (8) and was variable with respect o surface 
phenotype. This difference in phenotype may be due to clonal 
variation. 
The kinetics of the establishment of the pro-B cell cul- 
tures described here suggested that the pro-B cell popula- 
tions were derived from many different cells rather than the 
result of clonal outgrowth. To initiate the cultures, 106 bone 
marrow cells/ml were plated on an S17 stromal ayer. After 
2 wk in culture, most of the myeloid cells died and multiple 
loci of lymphopoietic cells grew. These foci replicated so that 
by 3-4 wk after initiation, the culture was populated with 
an average of 5 x l0 s pro-B cells/ml. 
These pro-B cells expressed receptors for IL-7 and SLF, but 
did not grow in response to these factors in soluble form. 
c-kit is a tyrosine kinase and if the kinase activity is abrogated, 
then downstream signals are not transduced and there is no 
response to SLF (49). Immunoprecipitation of c-kit from pro-B 
cells indicated that the full-length protein with normal evels 
of autokinase activity was produced (Faust, E., and O. Witte, 
unpublished observation). Therefore, adefect in c-kit kinase 
activity does not explain the lack of response to SLF in pro-B 
cells. 
The lack of growth in response to IL-7 could reflect a block 
downstream of the IL-7 receptor that renders the cells non- 
responsive to IL-7. n-myc and c-myc expression is induced in 
pre-B cells in response to IL-7 (50). The absence of n-myc 
in pro-B cells correlated with the nonresponsiveness to IL-7. 
IL-7 response has also been correlated to Ig gene rearrange- 
ments (8). Cells expressing C/z are the most sensitive to IL-7. 
The lack of C# protein and the paucity of IgH rearrange- 
ment in the pro-B cells correlates with the lack of response 
to IL-7. 
McNiece et al. (17) have reported that pro-B cells respond 
to IL-7, but only when 11.-7 is used in combination with SLF. 
This conclusion is in contrast o our studies and may be a 
reflection of different arget populations. McNiece et al. (17) 
showed that bone marrow depleted of cells expressing B220 
(B220-) differentiated into B220 § cells when cultured in 
IL-7 and SLF. The B220- population may have been con- 
taminated with pre-B cells. Billips et al. (22) showed that 
depletion of bone marrow required several rounds of deple- 
tion to remove all B220 + and C/x + pre-B ceils. This group 
(22) went on to show that after several rounds of depletion, 
B220- bone marrow did riot respond to either IL-7 or SLF. 
We have tested various cytokines, in addition to IL-7 and 
SLF, to identify those that are important in the growth of 
pro-B cells. IL-3 was tested because two different groups have 
reported the isolation of IL-3-dependent primitive B lineage 
clones (16, 18). Pro-B cells did not grow in medium sup- 
plemented with up to 20% WEHI-3 supernatant, a source 
of IL-3 (Faust, E., and O. Witte, unpublished observation). 
M-CSF was also tested since pro-B cells express mRNA for 
c-f ms and because bipotential precursors of B cells and mac- 
rophages that respond to M-CSF have been identified by sev- 
eral groups (3, 51, 52). Preliminary results indicated that 
M-CSF cannot substitute for the S17 stromal ayer in sup- 
porting the growth of pro-B cells. A recent report demon- 
strated that insulin-like growth factor 1 (IGF-1), which is 
produced by S17 stroma, was a differentiation factor for early 
B cells (53). Attempts to maintain pro-B cells in IGF-1 have 
failed (Faust, E., and O. Witte, unpublished observation). 
The majority of cells within the pro-B cell population re- 
quired cellular contact with the stromal ayer for growth, 
whereas asmall subset could respond to a secreted factor. The 
critical factor(s) produced by S17 could be produced in a 
membrane-bound and secreted form similar to M-CSF and 
SLF (54, 55). The bulk of the cells may respond only to the 
membrane-bound form, whereas asubpopulation can respond 
to the secreted form. The pro-B cell cultures described here 
provide a useful system to identify such factors and examine 
the role of known or novel genes and molecules in the growth 
and differentiation of early B cells. 
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